research Dermatological Manifestations During and After COVID-19: A Narrative Review
COVID-19 can cause skin issues like rashes and hair loss, which may last even after recovery.
Search
for
Sort by
Research
450-480 / 712 results
research Pathogenesis, Clinical Manifestations, and Laboratory Findings of COVID-19
COVID-19 affects multiple body systems and complicates treatment; accurate testing is crucial.
research Functional Medical Approach and Management for Long COVID
A functional medicine approach may help long COVID patients by focusing on adrenal fatigue, gut health, and vitamin D deficiency, using diagnostic tools and lifestyle changes.
research Sequelae of Long Covid, Known and Unknown: A Review of Updated Information
The review indicates that understanding of long COVID symptoms is still limited and better research is needed for diagnosis and treatment.
research Covid Lines
A man had nail and hair changes months after severe Covid-19, showing long-term effects.
research Role of ACE2 Polymorphism in COVID-19: Impact of Age
Different ACE2 gene versions may affect COVID-19 impact based on age and suggest some hair loss drugs could be potential treatments.
research Can Hydroxychloroquine Be Useful in the Prevention of COVID-19? An Italian Survey in Dermatologic and Rheumatologic Patients Already Under Treatment
Hydroxychloroquine might help prevent COVID-19, but more research is needed.
research Use of Antiandrogens as Therapeutic Agents in COVID-19 Patients
Antiandrogens might help prevent or treat COVID-19 by blocking the virus's entry into cells.
research A Concomitant Diagnosis of COVID-19 Infection and Systemic Lupus Erythematosus Complicated by a Macrophage Activation Syndrome: A New Case Report
COVID-19 may trigger systemic lupus erythematosus, requiring careful diagnosis and treatment.
research Effects of 5-Alpha Reductase Inhibitors on Lung Function: A Reason for Discontinuation During COVID-19 Pandemic?
5-alpha reductase inhibitors might worsen lung recovery in COVID-19 patients, suggesting a pause in their use.
research Dynamic and Spatial Transcriptional Responses in COVID-19-Related Chilblains
COVID-toes show a unique immune response over time, different from vaccine-related chilblains.
research A Systematic Review on Drug Re-Profiling/Re-Purposing
The document concludes that drug repurposing, which is reusing known medicines for new illnesses, can provide faster, cheaper treatment options for various serious diseases, including cancer, COVID-19, and rare diseases.
research Sex Differences in COVID-19: The Role of Androgens in Disease Severity and Progression
Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.
research In Silico Screening of DrugBank Compounds as Potential Inhibitors for Human Steroid 5α-Reductase 2 for Androgen-Related Diseases
Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.
research Resolution of Advanced Conjunctival Squamous Cell Carcinoma with Cemiplimab Immunotherapy, IFNα-2b, and Retinoic Acid Treatment Over 2 Years of Follow-Up
A woman with advanced eye cancer went into complete remission using a combination of immunotherapy and topical treatments.
research Hair Loss After SARS-CoV-2 Infection
Covid-19 can cause different types of hair loss, which can affect people's mental and social well-being.
research Alopecia and Grey Hair Are Associated with COVID-19 Severity
Having a lot of gray hair and hair loss are linked to more severe COVID-19.
research COVID-19 Clinical Outcomes and Nationality: Results from a Nationwide Registry in Kuwait
Non-Kuwaiti COVID-19 patients had worse health outcomes than Kuwaitis, likely due to poorer socioeconomic conditions.
research Host Genetic Susceptibility and Impacts of Dietary Factors on COVID-19
Certain genes and nutrients like vitamin D, zinc, and omega fatty acids affect COVID-19 severity and infection risk.
research Serum Vitamin D, Ferritin, and TSH in Patients with Telogen Effluvium: A Retrospective Epidemiological Study
Many patients with hair loss had low iron and vitamin D levels, but thyroid issues were not common.
research Comparison Between HPLC and Immunoturbidimetry for Glycated Hemoglobin (A1c) Measurement as a Diagnostic Criterion for Diabetes Mellitus
HPLC may detect prediabetes and diabetes earlier than Immunoturbidimetry because it shows higher A1c levels.
research Prevalence of Respiratory Disorders in Patients With Cleft Lip and Palate: Systematic Review
People with cleft lip and palate often have respiratory problems.
research The Covid-19 Vaccination: Autoimmune Phenomenon Alopecia Areata
COVID-19 vaccines may cause hair loss in people who are genetically prone to it.
research Profile and Clinical Character of COVID-19 Patients at Zahirah Hospital, South Jakarta
Older men with diabetes were more likely to get severe COVID-19 and needed treatments like antivirals for about 2-3 weeks.
research Profile and Clinical Character of COVID-19 Patients at Zahirah Hospital, South Jakarta
Older men with diabetes were more likely to get severe COVID-19 and needed treatments like antivirals for about 2-3 weeks.
research A Prospective Cross-Sectional Study on Post COVID-19 Hair Loss at a Tertiary Care Hospital
Many patients experienced severe hair loss after COVID-19, especially older adults and women.
research Hair Disorders Associated With Post-Covid-19 Infection in Females: A Cross-Sectional Study
About 61% of women who had COVID-19 experienced hair loss afterward.
research Evaluation of Patients with Telogen Effluvium During the Pandemic: Are Monocytes Responsible for Post COVID-19 Telogen Effluvium?
Monocytes might be linked to hair loss after COVID-19.
research Azithromycin With Nitazoxanide, Hydroxychloroquine or Ivermectin, With or Without Dutasteride, for Early Stage COVID-19: An Open-Label Prospective Observational Study in Males With Mild-to-Moderate COVID-19 (The Pre-AndroCoV Male Trial)
Early treatment with certain drug combinations improved COVID-19 outcomes and prevented severe disease in males, including those at higher risk.
research Azithromycin With Nitazoxanide, Hydroxychloroquine or Ivermectin, With or Without Dutasteride, for Early Stage COVID-19: An Open-Label Prospective Observational Study in Males With Mild-to-Moderate COVID-19 (The Pre-AndroCoV Male Trial)
Men with male pattern baldness had worse COVID-19 symptoms, but early treatment with certain drugs improved outcomes for all.